You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TP53 mutant myelodysplastic syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

Terminated
  • MDS
  • Myelodysplastic Syndromes
  • APR-548 + Azacitidine
  • Tampa, Florida
  • +3 more
Jul 20, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)

Completed
Has Results
  • Myelodysplastic Syndrome
  • +3 more
  • Tampa, Florida
  • +5 more
Jan 14, 2022

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

Not yet recruiting
  • NSCLC
  • Non-small Cell Lung Cancer
  • Apatinib + Fluzoparib
  • Apatinib + Fluzoparib + Adebrelimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 27, 2023

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Non Small Cell Lung Cancer Trial in Italy (Osimertinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Ancona, Italy
  • +10 more
Mar 14, 2023

Li-Fraumeni Syndrome, TP53 Gene Mutation, Hereditary Cancer Syndrome Trial in Boston (Data and Specimen Collection)

Recruiting
  • Li-Fraumeni Syndrome
  • +4 more
  • Data and Specimen Collection
  • Boston, Massachusetts
  • +2 more
Jan 23, 2023

Acute Myeloid Leukemia or MDS Trial in United States (APR-246)

Completed
  • Acute Myeloid Leukemia or Myelodysplastic Syndromes
  • Tampa, Florida
  • +6 more
Jan 18, 2022

Tumors, Ovarian Cancer, Breast Cancer Trial in Houston (ZN-c3, Bevacizumab, Pembrolizumab)

Not yet recruiting
  • Tumors
  • +4 more
  • Houston, Texas
    MD Anderson Cancer Center
Jun 20, 2022

Colorectal Cancer Trial in Salt Lake City (Cetuximab)

Recruiting
  • Colorectal Cancer
  • Salt Lake City, Utah
  • +1 more
May 3, 2022

Patients With Breast Cancer and Pathogenic Variants of TP53

Completed
  • Breast Cancer
  • +3 more
  • No intervention in this study
  • São Paulo, Brazil
    ICESP
Aug 5, 2022

MDS, Ferroptosis Trial in Pessac (Biological sampling)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Ferroptosis
  • Biological sampling
  • Pessac, France
  • +2 more
Jun 19, 2023

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Clinical and Genetic Studies of Li-Fraumeni Syndrome

Recruiting
  • Li-Fraumeni Syndrome
  • +2 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Li-Fraumeni Syndrome, Li-Fraumeni-Like Syndrome Trial in Philadelphia (No Intervention)

    Recruiting
    • Li-Fraumeni Syndrome
    • Li-Fraumeni-Like Syndrome
    • No Intervention
    • Philadelphia, Pennsylvania
    • +1 more
    Jan 2, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Biospecimen Collection
    • +2 more
    • Orange, California
    • +9 more
    Jan 27, 2023

    Acute Myeloid Leukemia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in Baltimore,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Baltimore, Maryland
    • +2 more
    Feb 25, 2022

    Myeloid Malignancy Trial in United States (APR-246, Venetoclax, Azacitidine)

    Completed
    • Myeloid Malignancy
    • New Haven, Connecticut
    • +7 more
    Jan 18, 2022

    Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

    Recruiting
    • Prevention of Chemotherapy-induced Myelosuppression
    • ALRN-6924
    • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
    • Tamarac, Florida
    • +14 more
    Jan 31, 2023

    Lung Cancer Trial in United States (Osimertinib, Platinum, Etoposide)

    Recruiting
    • Lung Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Jul 1, 2022

    Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

    Completed
    • Anemia in Myelodysplastic Syndromes
    • Plantation, Florida
    • +2 more
    Apr 4, 2022

    Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Magrolimab
    • +6 more
    • Duarte, California
    • +25 more
    Feb 4, 2022

    Myelodysplastic Syndrome With Gene Mutation, Acute Myeloid Leukemia With Gene Mutations, Myeloproliferative Tumor Trial in

    Unknown status
    • Myelodysplastic Syndrome With Gene Mutation
    • +3 more
    • Lille, France
    • +6 more
    Jan 29, 2020

    Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

    Active, not recruiting
    • Clinical Stage III Gastric Cancer AJCC v8
    • +7 more
    • Duarte, California
    • +30 more
    Jan 7, 2023

    MDS, Acute Myeloid Leukemia, Myeloid Malignancy Trial in Guangzhou (Sodium stibogluconate)

    Recruiting
    • Myelodysplastic Syndromes
    • +5 more
    • Sodium stibogluconate
    • Guangzhou, Guangdong, China
      First Affiliated Hospital of Jinan University
    Jun 5, 2021